59.9
Aytu BioPharma, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
Assets
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
72.8
FY24:
61.9
FY25:
79.2
FY26:
61.8
(positive)
Change from FY22 to FY26
millions USD
FY22:
77.7
FY23:
63.6
FY24:
56.2
FY25:
45.0
FY26:
43.2
Total assets
Change from FY22 to FY26
millions USD
FY22:
138
FY23:
136
FY24:
118
FY25:
124
FY26:
105
Liabilities & Equity
(negative)
Change from FY22 to FY26
millions USD
FY22:
64.4
FY23:
69.0
FY24:
62.2
FY25:
63.1
FY26:
54.7
(negative)
Change from FY22 to FY25
millions USD
FY22:
28.9
FY23:
28.1
FY24:
28.2
FY25:
42.1
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
44.3
FY23:
39.4
FY24:
27.7
FY25:
19.0
FY26:
35.3
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
138
FY23:
136
FY24:
118
FY25:
124
FY26:
–
All amounts in millions USD